chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On 1/10/01, the pt developed localized redness, warmth, swelling, itchiness, fever of 99.6 and dizziness.
J96.00 ACUTE RESPIRATORY FAILURE 4/14/2022 BENIGN NEUROENDOCRINE TUMOR, STOMACH
No additional adverse effects reported; a patient was administered an improperly stored dose of either VAQTA, PEDVAX HIB, or GARDASIL9; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent condition, concomitant medication and drug reactions/allergies were not provided.  On 19-DEC-2019, the patient was administered an improperly stored dose of either hepatitis a vaccine, inactivated (VAQTA) (lot# S010727, expiration date 26-JUL-2020, dose detail, strength and route were not provided), haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) (lot# S006471, expiration date 22-JAN-2022, dose detail, strength and route were not provided) or hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (lot# 1621926, expiration date 28-NOV-2021, dose detail, strength and route were not provided) for prophylaxis (product storage error). The temperature excursions included 34.9 Fahrenheit degree for 7 minutes and 48.2 Fahrenheit degree for 5 hours. There was no temperature previously excursion. There was a data logger involved. The medical assistant could not confirm during the call which of these products the patient received. No additional adverse effects were reported.
Moderna booster #2 was administered on 03/31/22 - the Facts Over Fear web page post with all the pertinent vaccine information, had it listed to give 0.5 ml of the red top Moderna vaccine for the #2 booster.  It was supposed to only be 0.25 ml.  This error was caught on 04/05/2022.  Patient was notified and no adverse effects were noted post vaccine.
Joint pain; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date (at the age of 33-years-old) as dose 1, single for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was unknown the patient receive any other vaccines or not within four weeks prior to the vaccination. On an unknown date the patient experienced joint pain. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event joint pain was unknown at the time of this report.   No follow up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Amendment: This follow-up report is being submitted to amend previously reported information: Patient age and Age at vaccination was added as 33 years in pt tab and analysis tab.
Patient had vaccine on 4/23/21 and developed calf pain on 4/26/21.   No other symptoms.  No other triggers known at that time for a DVT.  US did confirm a small blood clot
red hot ring on the arm; red hot ring on the arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (red hot ring on the arm) and VACCINATION SITE ERYTHEMA (red hot ring on the arm) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced VACCINATION SITE WARMTH (red hot ring on the arm) and VACCINATION SITE ERYTHEMA (red hot ring on the arm). At the time of the report, VACCINATION SITE WARMTH (red hot ring on the arm) and VACCINATION SITE ERYTHEMA (red hot ring on the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
itching; irritation; hives/they are welty feeling and looking; This is a spontaneous report from a contactable nurse. A 48-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, from 02Jan2021 16:45 to 02Jan2021 16:45 at 0.3 mL, single for covid-19 immunization. Medical history reported as "none". There were no concomitant medications. The patient noticed hives on the back of her legs this morning 05Jan2021. She has taken oral Benadryl which took all the itching and irritation away but the hives are still there. Further described as "they are welty feeling and looking". She added that she was not scheduled for the second injection yet, they told her to wait for an email to arrive for her to set it up. She has informed her primary HCP of her hives. Outcome of events itching and irritation was recovered whereas the patient had not recovered from hives at the time of this report.
A spontaneous report was received from a health care professional concerning a 67-year-old female patient who experienced backpain going down her spine, swollen along the spine, paresthesia  in her neck and upper spine, spots shape like the pox, light red colour, and numbness through out her upper and lower extremities after receiving the Moderna COVID-19 vaccine. The patient's medical history included an episode of herpes zoster infection that occurred about 3 years prior, diabetes, and high cholesterol. Concomitant medications reported included "cholesterol", metformin, and omeprazole. On 02 Jan 2021 the patient received the first of two planned doses of mRNA-1273 (lot number 037K20A) intramuscularly for prophylaxis of COVID-19 infection. On 04 Jan 2021, day2 after vaccination, she had rash with pain and swelling of the upper spine and shoulder area (which was similar to the rash of herpes zoster infection 3 years ago) and generalized paresthesia (tingling and numbness) of all extremities. From day 5 after vaccination all the symptoms started alleviating. There is no report of any treatment given to the patient for her symptoms. Action taken with mRNA-1273 in response to the events was not provided. The outcome of the events was reported as resolving.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
headache, malaise, vomiting, right arm pain has subsided  1st vaccination: 1/27/21 0830, 2nd vaccination: 3/10/21 0830
Headache, Myalgia, Fever, Fatigue Narrative:  Moderate fever, severe headache, moderate muscle pain and moderate fatigue. resulted in unable to work 1/26/2021 and 1/27/2021.
Rash began to appear on left inner aspect of arm. It is the only place the rash developed. Had a red dry appearance. Was itchy. Patient came out of the room to inform the nurse. The doctor was notified immediately as well as an extensive reparatory assessment. No wheezing, cough, or vomiting presented while patient remained in the office. 50mg BENADRYL given PO in office and hydrocortisone ointment prescribed script sent to the pharmacy. All activity occurred over about 30 min.
Patient lost consciousness, fell to the floor and hit her head, was disoriented for several minutes then was evaluated by ems and went to er for evaluation of head injury
Marked erythema, warmth, and edema of the left deltoid. Motin 200 mg q 6 hrs ordered X 2 days.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. No information on the patients' concomitant medications, concurrent conditions, pertinent medical history, drug reactions or allergies was reported. On unknown dates between 07-JUN-2016 and 08-DEC-2016, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB (lot # L048236 with expiry date on 31-MAR-2018, lot # L039660 with expiry date on 04-FEB-2018 and lot # L040458 with expiry date on 04-FEB-2018; dose and route of administration were not reported) for prophylaxis. On 07-JUN-2016, administered doses of RECOMBIVAX HB underwent a temperature excursion of minimum 25 degrees Fahrenheit for 12 hours prior to being administered. There were no known adverse effects. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1612USA010752: US-009507513-1612USA010753: US-009507513-1612USA004642.
This spontaneous report as received from a pharmacist refers to a 69 years old female patient with immunization. The patient was vaccinated with, .65 ml ZOSTAVAX [Lot # H017447, exp 20-DEC-2013] on 06-DEC-2012. No other co-suspects were reported. No concomitant medications were reported. On 06-DEC-2012 the patient experienced tingling and numbness throughout her body intermittently about 3 to 4 times within 30 minutes of vaccination. The patient was being observed in the pharmacy by the pharmacist at the time of reporting. No treatment information was reported. The outcome of tingling and numbness throughout her body is unknown. The relatedness for tingling and numbness throughout her body is unknown for ZOSTAVAX. Additional information has been requested.
FLU LIKE SYMPTOMS, INDURATION AT SITE AND BEYOND, APPROX 14 CM BY 7 AND ONE HALF CM ACCOMPANIED BY PAIN, ITCHING, REDNESS, AND SWELLING. SIGNS AND SYMPTOMS LASTED 10 DAYS.
pt recv vax & exp pain, redness & swelling @ inj site & had trouble sleeping;
I was given the shot about 2 pm. It was very high on the left arm almost to the shoulder. It hurt more than usual going in. I went home. By .5 pm I could not move my left arm at all without severe pain. This continued for 3 days - no possible use of the arm at all. On day 4 I could move forward and backward a couple of inches still no movement to the side without severe pain.  Slowly I regained movement. At 2 weeks I could raise my arm forward strait out in front of me and sideways 1/2 way to a T position At 3 weeks I could raise my arm forward and straight up over my head and sideways to a T position.  It's now been 4 weeks and I can raise my arm over my head both forward and sideways, Going sideways hurts a little.  Also reaching behind me or doing a swimming motion hurts a little.  If I do a motion that hurts a little, my shoulder will ache deep inside for a few minutes afterwards. I also had the usual vaccine effects of low grade fever and not much energy for about 3 days after the shot.
common side effects; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Jun-2021 and was forwarded to Moderna on 04-Jun-2021.    This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 06-Jun-2021 and was forwarded to Moderna on 06-Jun-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (common side effects) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Elevated blood pressure reading without diagnosis of hypertension. Concomitant products included AMLODIPINE for an unknown indication.    On 04-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jun-2021, the patient experienced ADVERSE REACTION (common side effects). At the time of the report, ADVERSE REACTION (common side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No relevant concomitant medication was reported.  Treatment medications were unknown. The action taken with mRNA-1273 in response to the event was not applicable.
The first 5 days I had cramping in my arms and cramping. 2-3 weeks the lymph nodes under armpits under both arms but more on the left side. Week between 4-6 I had chest pains. I did a EKG and ringing in my ears and everything turned out fine and went PT for the chest pains. The ringing in the ear has not stopped.
Mild pain; Axillar swelling (started 19 days ago) and residual swelling; A spontaneous report was received from physician concerning a 47 years old male patient who developed mild pain and  tenderness (Pain) , an adenopathy( Adenopathy), and axillary swelling (Swelling) 19 days after receiving Moderna vaccine mRNA-1273..   The patient's medical history included hypertension. Products known to have been used by the patient, within two weeks prior to the event, included Lisinopril and Vitamins.   The patient received his first of two planned doses of mRNA-1273 (Batch number: 011J2018 ) on 25 Dec 2020 intramuscularly in the left arm for prophylaxis of COVID-19 infection.    On 25 Dec 2020 the patient experienced axillary swelling which continues to the date of the report, pain and tenderness, and adenopathy The event adenopathy was assessed as medically significant. Treatment for the event included Ibuprofen and Acetaminophen.   Action taken with mRNA-1273 in response to the event(s) was not provided.  The outcome of the event(s) axillar swelling (started 19 days ago) and residual swelling, tenderness, mild pain and an adenopathy were  unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded
sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 22Apr2021 12:30 (Lot number: EW0175) at the age of 47 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "asthma" (ongoing), notes: Inhaler is treatment; "menstrual" (ongoing); "allergies" (ongoing); "Headache" (ongoing). Family history included: "high blood pressure" (ongoing), notes: Medicine controls. Concomitant medication(s) included: LISINOPRIL taken for blood pressure abnormal (ongoing); ADVIL 12 HOUR taken for headache, menstrual disorder (ongoing); TYLENOL taken for headache (ongoing); BENADRYL taken for hypersensitivity (ongoing); ALBUTEROL [SALBUTAMOL] taken for hypersensitivity (ongoing); QVAR taken for asthma (ongoing). The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 23Apr2021, outcome "unknown", described as "sore arm". Therapeutic measures were not taken as a result of vaccination site pain.  Follow-up attempts are completed. No further information is expected.
11:00 Generalized rash and itching to H1N1 vaccine. Pt. c/o itching, she was observed scratching B UES and B LES. BENADRYL 50 mg was administered IM to R arm. Pt. reported no improvement after 30 minutes, Dr. was consulted to obtain permission to administer a 2nd dose of BENADRYL. Informed Dr. pt. weighs 80 kg. 11:35-2nd dose of BENADRYL 50 mg IM given to L arm. 11:55 AM Pt. reported feeling better. 12:00 Pt. went back to work.
Post vax, on 10/09/2001 the patient broke out with 50 pox. By 10/15/2001 she had 150 pox. The patient complained of being tired and itchy. No other symptoms.
Patient had an episode of fainting (possible syncope ?) approximately 5  minutes after receiving vaccination. She was sitting on a chair while waiting for the 15 minutes post-vaccination observation. She fainted and fell on the ground. But she was conscious and was able to respond normally. At the end, she was feeling fine. She explained it has happened to her a few times in the past when she had blood drawn.
Information has been received from a physician concerning a 23 year old female patient with the medical history of high blood pressure who on 14-FEB-2011 was vaccinated intramuscularly with the first dose of GARDASIL (Lot# 662529/1317Y, Expiration: 30-May-2011).  Concomitant therapy included MICARDIS for her high blood pressure and ethinyl estradiol (+) etonogestrel (MSD).  The physician reported that the patient had a rash and increased blood pressure.  On 23-FEB-2011 the patient went back to the physician because of the onset of the rash which started on 16-FEB-2011.  It was on her arm and leg and it was itchy and blotchy.  One thing to note about the increased blood pressure, she was on MICARDIS (manufacturer unspecified).  She was also on ethinyl estradiol (+) etonogestrel (MSD) prior to getting the GARDASIL vaccine.  One thing her primary doctor added after the AE was the metoprolol 50mg (manufacturer unspecified).  She did visit her primary care physician and that's who prescribed it.  At time of report, the patient's status was unknown.  Blood pressure increased was considered to be another important medical event by the reporter.  Additional information has been requested.
Estimated due date of pregnancy was november 2021. We experienced a miscarriage during the vaccine symptoms of the first shot. The second dose of vaccine was way worse than the first. I got a sore arm, aches, a headache, nausea, a fever, chills, pins and needles feelings in my hands and feet, heartburn, and dizziness. I kept feeling like I might throw up and I developed a great big rash on my arm again, called covid arm. I spent the entire day on the couch next to a bucket because if I got up, I was too light headed and nauseated to do anything. It lasted 24 hours or so. By day 3 after the shot, I felt okay other than soreness, a headache, and a big itchy rash at the injection site. We are concerned about the miscarriage but don't know if it was or wasn't related to the vaccine. I did have a big reaction and we wonder if my immune system gearing up targeted the very early fetus as an intruder. We are deeply saddened by our loss.
Should be given Covid vaccine for 5-11 years.  Gave Covid 12 + for 11 year old patient.  No symptoms, no adverse reaction.  Patient takes it well.  Mother informed in office.  Patient monitors for 20 minutes and all okay then left the office.
Numb and Tingly on hands and across stomach. Nausea/vomiting, headache.
While talking to my parents I started to say things completely opposite of the conversation we were having. My speech began to slur and then I passed out/fainted and was unconscious for approx 1 minute. Once I came to I was disoriented and nauseated.
L arm red swollen 3 cm L axillary mass KEFLEX 500mg QID x 5 days.
Information has been received from a nurse referring to an unspecified number of unspecified patients of unknown age and gender. On unknown dates the patients were vaccinated with improperly stored VAQTA (lot # L018499, expiration date 25-FEB-2017, strength, dose, lot#, expiration date and route were unknown). No adverse events were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Got diagnosed with mild stroke after a high blood pressure crisis; Got diagnosed with mild stroke after a high blood pressure crisis; blurry vision on the left eye; Pins and needles feelings in left body side; headache; memory loss; This is a spontaneous report from a contactable consumer (reporting for herself). A 49-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Right on 13Mar2021 at 10:00 (Batch/Lot number was not reported) as 1ST DOSE, SINGLE for COVID-19 immunization. Medical history included high blood pressure, and asthma. The patient's concomitant medications were not reported. On 14Mar2021, the patient was diagnosed with mild stroke after a high blood pressure crisis and the symptoms showed days after the vaccine such as blurry vision on the left eye, pins and needles feeling in left body side, headache and memory loss. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on an unspecified date. The outcome of the events was unknown. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. The events resulted in emergency room/department or urgent care and was admitted in the hospital for 2 day. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has been tested for COVID-19 since the vaccination.  Information on the lot/batch number has been requested.
This spontaneous report as received from a medical assistant refers to a 15 month old patient of unknown gender. The concurrent conditions, drug reactions/allergies and medical history of the patient were not reported.  On 14-NOV-2016, the patient was vaccinated with a dose of improperly stored Measles, Mumps, and Rubella Virus Vaccine (manufacturer unknown) (strength, dose, route of administration, anatomical location, lot number and expiration date were unknown) for prophylaxis, which was stored at 1.1 Celsius degrees (°C) for 27 minutes, 0.7 °C for 19 minutes, 1.1 °C for 36 minutes, 0.7 °C for 29 minutes, 1.3 °C for 17 minutes, 1.1 °C for 20 minutes, 0.9 °C for 26 minutes, 0.7 °C for 31 minutes and 1.2 °C for 24 minutes. There was no previous temperature excursion. Moreover, the temperature excursions were detected by a data logger. No concomitant therapies nor adverse effects were reported. No product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1701USA007910: US-009507513-1701USA004148: US-009507513-1701USA003168: US-009507513-1701USA007912: US-009507513-1701USA007922: US-009507513-1701USA007881: US-009507513-1701USA007913: US-009507513-1701USA007882: US-009507513-1701USA004150: US-009507513-1701USA007958: US-009507513-1701USA007895: US-009507513-1701USA007896: US-009507513-1701USA007923: US-009507513-1701USA004152: US-009507513-1701USA007883: US-009507513-1701USA007897: US-009507513-1701USA007905: US-009507513-1701USA007884: US-009507513-1701USA007924: US-009507513-1701USA007925: US-009507513-1701USA007847: US-009507513-1701USA007885: US-009507513-1701USA007908: US-009507513-1701USA007909: US-009507513-1701USA007898: US-009507513-1701USA007914: US-009507513-1701USA007915: US-009507513-1701USA007916: US-009507513-1701USA007848: US-009507513-1701USA007849: